Bioequivalence
Bioequivalence is a pharmaceutical equivalence criterion based on the absence of a statistically significant difference between two drug formulations in the rate and extent of active pharmaceutical ingredient bioavailability at the site of drug action.
1.9K
Publications
69.9K
Citations
7.1K
Authors
1.9K
Institutions
Publications per year
2017–2026
286
Variants
Bioequivalence Studies
Parents
1.9K
1–5 of 1.9K
7.1K
23
h-index
20
h-index
18
h-index
18
h-index
15
h-index
1–5 of 7.1K
1.9K
Center for Drug Evaluation and Research
Silver Spring, United States
36 h-index
292 publications
20.2K citations
United States Food and Drug Administration
Silver Spring, United States
33 h-index
255 publications
13.5K citations

University of Toronto
Toronto, Canada
21 h-index
48 publications
1.3K citations
Bristol-Myers Squibb (United States)
New York, United States
21 h-index
88 publications
4.1K citations
Novartis (Switzerland)
Basel, Switzerland
20 h-index
73 publications
2K citations
Pfizer (United States)
New York, United States
18 h-index
68 publications
2.3K citations

Research Triangle Park Foundation
Durham, United States
17 h-index
48 publications
2.2K citations
Zimmer Biomet (Germany)
Berlin, Germany
17 h-index
46 publications
2K citations
1–8 of 1.9K
68 publications · 4K citations
35
h-index
Repository · 129 publications · 3.7K citations
32
h-index
81 publications · 2.6K citations
30
h-index
CPT · 39 publications · 1.6K citations
24
h-index
45 publications · 2.9K citations
24
h-index
1–5